SRCL Stericycle Inc.

Scott+Scott, Attorneys at Law, LLP Is Investigating Derivative Claims on Behalf of Shareholders of Stericycle, Inc. (SRCL)

Scott+Scott, Attorneys at Law, LLP (“Scott+Scott”), a national shareholder and consumer rights litigation firm, is investigating whether certain officers and directors of Stericycle, Inc. (“Stericycle” or the “Company”) (NASDAQ: SRCL) breached their fiduciary duties owed to the Company and its shareholders. If you are a holder of Stericycle common stock, you are encouraged to contact a Scott+Scott attorney at (844) 818-6982 for additional information.

Stericycle, Inc. is a business-to-business services provider focused on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s primary business is as an international waste management and disposal company that specializes in collecting and disposing regulated waste, including medical, pharmaceutical, and hazardous waste.

Scott+Scott is investigating whether members of Stericycle’s Board of Directors breached their fiduciary duties by failing to implement appropriate internal procedures and controls to prevent the Company and its top executives from allegedly violating contracts and defrauding clients of hundreds of millions of dollars through an automatic price-increase scheme.

What You Can Do

If you are a Stericycle shareholder, you may have legal claims against Stericycle’s officers and directors. If you wish to discuss this investigation, or have questions about this notice or your legal rights, please contact attorney Joe Pettigrew at (844) 818-6982, or at [email protected].

About Scott+Scott, Attorneys at Law, LLP

Scott+Scott has significant experience in prosecuting major securities, antitrust, and employee retirement plan actions throughout the United States. The firm represents pension funds, foundations, individuals, and other entities worldwide with offices in New York, London, Connecticut, California, and Ohio.

EN
04/10/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Stericycle Inc.

 PRESS RELEASE

Stericycle to Participate in Stifel 2024 Investor Summit at WasteExpo...

Stericycle to Participate in Stifel 2024 Investor Summit at WasteExpo in May BANNOCKBURN, Ill., April 30, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: SRCL) today announced that Cindy J. Miller, Chief Executive Officer, and Janet Zelenka, Chief Financial Officer and Chief Information Officer, will participate in a fireside chat and investor meetings at the Stifel 2024 Investor Summit at WasteExpo in Las Vegas on Monday, May 6, 2024. About StericycleStericycle, Inc., is a U.S. based business-to-business services company that is celebrating 35 years of protecting what matters.  As a leading provide...

 PRESS RELEASE

Stericycle to Participate in Oppenheimer 19th Annual Industrial Growth...

Stericycle to Participate in Oppenheimer 19th Annual Industrial Growth Conference in May BANNOCKBURN, Ill., April 30, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: SRCL) today announced that Ritu Narula, Vice President Treasury, and Andrew Ellis, Senior Vice President Finance, will participate in investor meetings at the virtual Oppenheimer 19th Annual Industrial Growth Conference on Wednesday, May 8, 2024. About StericycleStericycle, Inc., is a U.S. based business-to-business services company that is celebrating 35 years of protecting what matters. As a leading provider of compliance-based solutio...

 PRESS RELEASE

Stericycle, Inc. Reports Results For The First Quarter 2024

Stericycle, Inc. Reports Results For The First Quarter 2024 BANNOCKBURN, Ill., April 25, 2024 (GLOBE NEWSWIRE) -- Stericycle, Inc. (Nasdaq: SRCL) today reported results for the first quarter ended March 31, 2024. Revenues for the first quarter were $664.9 million, a decrease of 2.8% compared to $684.3 million in the first quarter of 2023. Income from operations was $38.9 million compared to $40.0 million in the first quarter of 2023. Net income was $13.1 million, or $0.14 diluted earnings per share, compared to $11.2 million, or $0.12 in the first quarter of 2023. Adjusted income...

 PRESS RELEASE

Stericycle, Inc. Reports Results For The Fourth Quarter 2023

Stericycle, Inc. Reports Results For The Fourth Quarter 2023 BANNOCKBURN, Ill., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Stericycle, Inc. (Nasdaq: SRCL) today reported results for the fourth quarter ended December 31, 2023. Revenues for the fourth quarter were $652.0 million, a decrease of 2.7% compared to $670.4 million in the fourth quarter of 2022. Income from operations was $37.1 million, compared to $59.1 million in the fourth quarter of 2022. Net income in the fourth quarter was $14.9 million, or $0.16 diluted earnings per share, compared to $31.8 million, or $0.35 in the fourth q...

 PRESS RELEASE

Stericycle to Present at Raymond James 45th Annual Institutional Inves...

Stericycle to Present at Raymond James 45th Annual Institutional Investors Conference in March BANNOCKBURN, Ill., Feb. 05, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: SRCL) today announced that Cindy J. Miller, Chief Executive Officer, and Janet Zelenka, Chief Financial Officer and Chief Information Officer, will present and host investor meetings at the Raymond James 45th Annual Institutional Investors Conference in Orlando, Florida, on Tuesday, March 5, 2024. About StericycleStericycle, Inc. is a U.S. based business-to-business services company and leading provider of compliance-based solutions...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch